Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · IEX Real-Time Price · USD
2.365
-0.015 (-0.63%)
At close: Jul 19, 2024, 12:00 AM
2.350
-0.015 (-0.63%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 377 employees as of December 31, 2023. The number of employees increased by 22 or 6.20% compared to the previous year.
Employees
377
Change (1Y)
22
Growth (1Y)
6.20%
Revenue / Employee
$454,525
Profits / Employee
-$170,825
Market Cap
350.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ModivCare | 21,200 |
Nevro | 1,215 |
Talkspace | 472 |
Kamada | 378 |
Vanda Pharmaceuticals | 203 |
AC Immune | 161 |
TScan Therapeutics | 154 |
Cabaletta Bio | 103 |
XERS News
- 14 days ago - Xeris Biopharma Announces CEO Succession Plan - Business Wire
- 18 days ago - Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing's Syndrome Patients at ENDO 2024 - Business Wire
- 7 weeks ago - Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121) - Business Wire
- 7 weeks ago - Xeris to Participate in the Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events - Business Wire
- 2 months ago - Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics - Business Wire
- 2 months ago - Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024 - Business Wire